• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

AMA to CMS: Changes Needed to Avoid Large Cuts in Physician Payments in 2021 Medicare Fee Schedule

Article

Without changes to next year's Medicare fee schedule, physician payment would be reduced by almost 11%. says the AMA.

The American Medical Association (AMA) announced its objections to the proposed 2021 Medicare fee schedule today, saying that budget neutrality rules would lead to a 5.5% cut in physician payment and that additional proposals would have the effect of ramping up the reduction to almost 11%. The AMA called on CMS to waive budget neutrality and avert the payment cuts.

The press release — which distilled 93 pages of technical comments that the association filed with CMS — also urged CMS to “treat all physicians fairly” by incorporating office visit increases into surgical global payment; to make permanent several telehealth services; and to implement and pay for the new CPT code 99072 that covers safety protocols related to COVID-19.

The AMA urged the agency to continue with policies that introduced “much-needed flexibility” to the Medicare Quality Payment Program and expressed strong support for a CMS new office visit policy that the AMA says will “significantly reduce administrative burdens and better describe and recognize the resources involved in office visits.”

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Related Content
© 2024 MJH Life Sciences

All rights reserved.